TRHLÍK, Martin, Renata SOUMAROVÁ, Pavel BARTOŠ, Jan KOLÁČEK, Ivanka HOROVÁ and Markéta TĚŽKÁ. Neoadjuvant chemotherapy for primary advanced ovarian cancer. Biomedical Papers. Univerzita Palackého v Olomouci, 2013, vol. 157, No 2, p. "S98", 1 pp. ISSN 1213-8118.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Neoadjuvant chemotherapy for primary advanced ovarian cancer
Authors TRHLÍK, Martin, Renata SOUMAROVÁ, Pavel BARTOŠ, Jan KOLÁČEK, Ivanka HOROVÁ and Markéta TĚŽKÁ.
Edition Biomedical Papers, Univerzita Palackého v Olomouci, 2013, 1213-8118.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 10103 Statistics and probability
Country of publisher Czech Republic
Confidentiality degree is not subject to a state or trade secret
WWW URL
Impact factor Impact factor: 1.661
Organization unit Faculty of Science
Keywords in English neoadjuvant chemotherapy; ovarian cancer
Tags International impact, Reviewed
Changed by Changed by: doc. Mgr. Jan Koláček, Ph.D., učo 19999. Changed: 10/3/2015 09:44.
Abstract
Primary debulking surgery before adjuvant chemotherapy (ACT) is the standard of care for patients with advanced ovarian cancer but neoadjuvant CT (NACT) is an alternative therapeutic approach in stage IIIC or IV disease. We evaluated our patients with NACT and its influence on radicality of surgery and overall survival (OS). We evaluated 138 women treated for advanced ovarian cancer of stage FIGO IIIC-IV not suitable for primary debulking surgery (PDS) because of unresectable tumor or poor performance status. All women underwent laparoscopic evaluation – confirming inoperable advanced ovarian cancer of stage IIIC-IV. After the NACT of 3-4 series was provided this was followed by laparoscopic reevaluation.
PrintDisplayed: 15/10/2024 19:52